Specialist Updates 
Cardiology

New evidence links paclitaxel-containing devices with mortality risk

But the PAD study shows no dose-response relationship and fails to identify a mechanism, researchers say
Clare Pain
0
12 May 2020
Save
suregon in theatre

UPDATED: 9 June 2020

A second meta-analysis has linked paclitaxel-containing devices used in peripheral artery disease (PAD) with increased long-term mortality risk.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .